DBV Technologies News and Activities

DBV Technologies is one of the...

• CAC All-Trade;
• SBF 120;
• TOB Iconic 10,000.

DBV Technologies is a company listed under the stock ticker DBV (FR).

View the org chart displaying its 41 main executives

Most searched biographies at DBV Technologies

• Daniel Tasse, Chief Executive Officer and Director
• Julie O'Neill, Director
• Ravi Rao, Board Member

Popular executive movements at DBV Technologies

• Kevin Trapp has joined the company as Chief Commercial Officer  (posted on November 4 2025).
• Philina Lee has joined the company as Director  (posted on October 31 2025).
• Daniel Soland, Director, has left the company  (posted on September 19 2025).

Create your alert
to follow the executive moves at DBV Technologies.

DBV Technologies has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by DBV Technologies

• DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq | DBV Technologies
• DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study | DBV Technologies
• DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old | DBV Technologies
• Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024 | DBV Technologies
• DBV Technologies Announces Plan to Implement ADS Ratio Change | DBV Technologies
• DBV Technologies Reports Third Quarter 2024 Financial Results | DBV Technologies
• DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe | DBV Technologies
• Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 | DBV Technologies
• DBV Technologies to Participate in Upcoming ACAAI 2024 Congress | DBV Technologies
• News | DBV Technologies
• View more press releases Close

Social media about DBV Technologies

• DBV Technologies on Wikipedia, Google News & Yahoo Finance
• DBV Technologies on LinkedIn, X (Twitter) & YouTube